Eflornithine and Lomustine Combination Shows Clinically Meaningful Improvements in Overall Survival (OS) and Progression Free Survival (PFS) in Patients with Recurrent Astrocytoma IDH Mutant Grade 3 by Seini Moimoi | Nov 22, 2024 | Portfolio News
89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024 by Seini Moimoi | Nov 22, 2024 | Portfolio News
First Patient Dosed in Endeavor BioMedicines’ Phase 2b WHISTLE-PF Trial Evaluating ENV-101 for the Treatment of Idiopathic Pulmonary Fibrosis by Seini Moimoi | Nov 20, 2024 | Portfolio News
Alentis Receives FDA Fast Track Designation for ALE.P02 for the Treatment of CLDN1+ Squamous Solid Tumors by Seini Moimoi | Nov 15, 2024 | Portfolio News
Epirium Bio Presented Late-Breaking Preclinical Data of MF-300 (15-PGDH Enzyme Inhibitor) at the Gerontological Society of America Annual Scientific Meeting 2024 by Seini Moimoi | Nov 13, 2024 | Portfolio News
